 rational manag hyperlipidemia nephrot syndrom hyperlipidemia present patient nephrot syndrom common lipid abnorm disord hypertriglyceridemia elev plasma lipid potenti vascular consequ atherosclerosi progress renal failur complic certainti evid long-term consequ nephrot syndrom effect therapi hyperlipidemia cholesterol level protect complic nephrot hypercholesterolemia sever dietari therapi valuabl adjunct cholesterol level nephrot patient effect serum cholesterol lower drug therapi acid-bind resin cholesterol level nephrot patient declin cholesterol concentr insuffici mark reduct coronari risk nicotin use treatment nephrot hyperlipidemia new drug cholesterol synthesi lovastatin elev cholesterol triglycerid nephrot syndrom drug condit possibl signific side effect appreci portion patient particular concern develop sever myopathi myoglobinuria acut renal failur side effect rare patient nephrot syndrom preval latter condit fibric acid triglycerid level nephrot patient effect cholesterol level littl role treatment nephrot hypercholesterolemia drug probucol cholesterol level nephrot patient desir level probucol use combin cholesterol-low drug